FEBS Open Bio, 2022 · DOI: 10.1002/2211-5463.13472 · Published: January 1, 2022
Spinal cord injury (SCI) often leads to sensory and motor dysfunction, complicated by local inflammation and glial scar formation. This study identifies key genes (hub genes) involved in the immune response after SCI, which could be targets for new therapies. The research analyzes gene expression changes over time in mice with SCI and validates these findings using qPCR and single-cell sequencing data.
Identified hub genes may serve as targets for developing immunotherapies to modulate the immune response following SCI.
Hub genes highly expressed in the blood of SCI patients could be developed into diagnostic biomarkers for SCI severity and progression.
Temporal expression patterns of hub genes can guide the optimal timing for therapeutic interventions aimed at modulating the immune response.